ciprofloxacin has been researched along with nitrofurantoin in 105 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (0.95) | 18.7374 |
1990's | 3 (2.86) | 18.2507 |
2000's | 28 (26.67) | 29.6817 |
2010's | 52 (49.52) | 24.3611 |
2020's | 21 (20.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S | 1 |
Hovde, LB; Kroeger, LA; Mitropoulos, IF; Rotschafer, JC; Schafer, J | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Jones, GL; Stickler, DJ | 1 |
Bethel, CR; Bonomo, RA; Carias, LL; Endimiani, A; Fox, WR; Hall, GS; Hujer, AM; Hujer, KM; Hutton, RA; Jacobs, MR; Jenkins, SG; Paterson, DL; Perez, F; Rice, LB; Tenover, FC | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Andersson, DI; Negrea, A; Pränting, M; Rhen, M | 1 |
Herrera, ML; Jorgensen, JH; Lewis, JS; Prakash, V; Wickes, BL | 1 |
Campbell, L; Church, DL; Gregson, DB; Laupland, KB; Pitout, JD | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Alfa, M; Kibsey, P; Loo, V; McGeer, A; Nigrin, J; Peirano, G; Pienaar, C; Pitout, JD; Richardson, D; Toye, B | 1 |
Blango, MG; Mulvey, MA | 1 |
Cars, O; Löwdin, E; Melhus, A; Tängdén, T | 1 |
Auer, S; Hell, M; Wojna, A | 1 |
Gozalbes, R; Pineda-Lucena, A | 1 |
Chen, X; Lin, X; Skolnik, S; Wang, J | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Ashenden, S; Bender, A; Cokol, M; Karakoc, I; Kuru, N; Mason, DJ; Meral, S; Stott, I; Weinstein, ZB | 1 |
Auer, JL; Cascio, F; Chowdhury, M; Hind, C; Picconi, P; Prabaharan, P; Rahman, KM; Sandiford, S; Sutton, JM; Wand, ME | 1 |
Ferro, S; Low, DE; Simor, AE | 1 |
Chen, SN; Lee, KK; Liu, PC | 1 |
Briefer, C; Echols, RM; Iravani, A; Klimberg, I; Kowalsky, SF; Munera, C | 1 |
Hartzema, AG; Huang, X; Kauf, TL; Norwood, GJ; Raasch, RH | 1 |
Carrie, A; Harding, GK; Hoban, DJ; Karlowsky, JA; Low, DE; Mazzulli, T; Zhanel, GG | 1 |
Astrup, AV; Høiby, N; Larsen, LA; Raben, A; Tvede, M | 1 |
Jones, ME; Karlowsky, JA; Kelly, LJ; Sahm, DF; Thornsberry, C | 1 |
Bernatoniene, G; Kaltenis, P; Murauskaite, G | 1 |
Baerheim, A; Digranes, A; Jureen, R | 1 |
Li, ZD; Shao, HF; Wang, WP; Zhang, XW | 1 |
Kamat, AM; Lamm, DL | 1 |
De Neeling, AJ; Geerlings, SE; Hoepelman, AI; Meiland, R | 1 |
Nowakowska, M; Radosz-Komoniewska, H; Rudy, M; Wiechuła, B; Zientara, M | 1 |
Bergus, GR; Ernst, EJ; Ernst, ME; Hoehns, JD | 1 |
Decorby, MR; Hoban, DJ; Karlowsky, JA; Laing, NM; Zhanel, GG | 1 |
Acar, B; Aysev, D; Ekim, M; Güriz, H; Kavaz, A; Ozçakar, ZB; Oztürk, B; Yalçinkaya, F; Yüksel, S | 1 |
Chazan, B; Colodner, R; Elias, M; Raz, R; Rock, W | 1 |
Lajiness, MJ | 1 |
Harrell, LJ; Kaye, KS; Olson, RP | 1 |
Amábile-Cuevas, CF; Arredondo-García, JL | 1 |
Kothari, A; Sagar, V | 1 |
Armero, C; Gobernado, M; González, F; López-Quílez, A; Perpiñán, H; Sahuquillo-Arce, JM; Selva, M; Vanaclocha, H | 1 |
Burström, B; Ericsson, O; Ljung, R; Reimers, A | 1 |
Chung, H; Hoshide, RR; Tokeshi, J | 1 |
Bordon, JM; Karlowsky, JA; Master, RN; Sanchez, GV | 1 |
Al Naiemi, N; Halaby, T; Nordmann, P; Potron, A; Reuland, AE; Savelkoul, PH; Vandenbroucke-Grauls, CM | 1 |
Katz, K; Lowe, CF; McGeer, A; Muller, MP | 1 |
Ahmad, S; Cullen, IM; Fennell, JP; Flynn, R; Grainger, R; Manecksha, RP; McCullagh, E; McDermott, TE; Murphy, P; O'Kelly, F; Thornhill, JA | 1 |
Haith, K; Olson, RP | 1 |
Bonomo, RA; Donskey, CJ; Drawz, PE; Hirsch, AA; Jump, RL; Jury, LA; Kypriotakis, G; Olds, DM; Peron, EP; Seifi, N; Watts, B | 1 |
Bleidorn, J; Gágyor, I; Hummers-Pradier, E; Schmiemann, G | 1 |
Abriouel, H; Benomar, N; Gálvez, A; Lavilla Lerma, L; Pérez Pulido, R; Sánchez Valenzuela, A | 1 |
Bachmann, A; Bonkat, G; Braissant, O; Frei, R; Gasser, TC; Müller, G; Rieken, M; Tschudin-Suter, S; Widmer, AF; Wyler, S | 1 |
Bearden, DT; Elman, MR; McGregor, JC; Smith, DH | 1 |
Goldfarb, DM; Mokomane, M; Narasimhamurthy, M; Renuart, AJ; Silverman, JA; Steenhoff, AP; Tawanana, EO | 1 |
Chen, Y; Meng, J; Rump, L; Shen, J; Wang, X; Zhang, Y | 1 |
Arab, R; Ezadi, H; Momtaz, H; Rahimi, E; Safarpoor Dehkordi, F | 1 |
Li, RH; Shang, XH; Wang, QY | 1 |
Cheong, HJ; Cho, YK; Choi, TY; Chung, MH; Kang, JO; Ki, M; Kim, J; Kim, SJ; Kim, Y; Kwon, KT; Lee, H; Lee, JS; Lim, SK; Pai, H; Park, DW; Ryu, SY; Seo, MR; Wie, SH | 1 |
Kwok, T; Mahmood, MN; Salopek, TG | 1 |
Delémont, C; François, P; Gaïa, N; Harbarth, S; Lazarevic, V; Malhotra-Kumar, S; Martinez de Tejada, B; Schrenzel, J; Stewardson, AJ | 1 |
Gandhi, S; Garg, AX; Jain, AK; Liu, AR; McArthur, E; Moist, L; Singh, N; Sood, MM | 1 |
Eliopoulos, GM; Hirsch, EB; Kim, Y; Kirby, JE; McCoy, C; Raux, BR; Wright, SB; Zucchi, PC | 1 |
Brair, A; Gray, J; Toozs-Hobson, P | 1 |
Chen, A; Eliopoulos, GM; Hirsch, EB; Kirby, JE; McCoy, C; Raux, BR; Zucchi, PC | 1 |
Babiker, A; Bordon, J; Luu, T; Master, RN; Mathur, A; Sanchez, GV | 1 |
Bernatchez, H; Boudreault, AA; Delisle, G; Domingo, MC; Gourdeau, M; Lavallée, C; Quach, C | 1 |
Araújo, MC; De Resende, EA; Lazo-Chica, JE; Miguel, CB; Nogueira, AP; Oliveira, CJ; Paulino, Tde P; Rodrigues, WF; Soares, Sde C; Ueira-Vieira, C | 1 |
Conigliaro, A; Grodin, L; Lee, SY; Rose, M; Sinert, R | 1 |
Ansari, L; Haghani, M; Masoomi, S; Momeni, F; Mortazavi, SA; Mortazavi, SMJ; Movahedi, MM; Ranjbar, S; Taeb, S; Taheri, M; Tajbakhsh, S; Zarei, S | 1 |
Barry, L; Corcoran, GD; Hooton, C; Lucey, B; O'Grady, MC; O'Halloran, C; Walsh, N | 1 |
Edeghere, O; Gossain, S; Hawkey, PM; Hilton, B; Hopkins, S; Ironmonger, D; Verlander, NQ | 1 |
Anğ-Küçüker, M; Arslan, C; Aydın, EM; Canlı, C; Çelik, E; Gümüş, D; Kalaycı-Yüksek, F; Uz, G; Yörük, E | 1 |
Aly, S; Fadel, A; Mabrok, M | 1 |
Holzknecht, BJ; Justesen, US; Lund, LC | 1 |
Fredheim, EGA; Johnsen, PJ; Kloos, J; Podnecky, NL; Primicerio, R; Roberts, AP; Rozen, DE; Samuelsen, Ø; Sørum, V | 1 |
Dowling, JAR; Forbes, S; Henly, EL; Lacey, MM; Maingay, JB; Smith, TJ | 1 |
Beckman, A; Hedin, K; Kornfält Isberg, H; Melander, E; Mölstad, S | 1 |
Gurbuz, Y; Korkmaz, N; Kul, G; Sandikci, F; Sencan, I; Tutuncu, EE | 1 |
Al-Tawfiq, JA; Bazzi, AM; Rabaan, AA; Saunar, JV | 1 |
Gales, AC; Martins, WMBDS; Minarini, LADR; Rando, DGG; Ribeiro, ÁCDS; Silva, AAD | 1 |
Li, T; Ma, X; Shi, W; Zhang, Y; Zheng, X | 1 |
Brunelli, R; Cai, T; Cipelli, R; Palagin, I; Pellini, E; Truzzi, JC; Van Bruwaene, S | 1 |
Haider Naqvi, SZ; Malik, A; Muddassir, M; Mumtaz, K; Munir, S; Raza, A; Shoaib Ahmed, S; Waqas, K | 1 |
Ebrahimzadeh, F; Gholami, S; Jafari-Sales, A; Rostami, A; Zadeh, FA | 1 |
Borges-Mateus, LM; Carmona-Cartaya, Y; González-Molina, MK; Hidalgo-Benito, M; Pereda-Novales, N; Quiñones-Pérez, D | 1 |
Pintarić, S; Štritof, Z; Tumpa, A | 1 |
Arendarski, P; Kramer, TS; Salm, F; Salm, J | 1 |
Alarfaj, AA; Hirad, AH; Kosanam, S; Ponsudha, P; Prasada Rao, CMM; Selvam, N; Sundaram, SR; Surendhar, PA; Suriyakrishnaan, K; Vennila, T | 1 |
Crawford, SB; Davis, WH; Geno, KA; Magee, MR; Monks, SM | 1 |
Dai, J; Hu, Q; Li, X; Liu, X; Luo, Y; Shen, F; Wu, N; Xu, Z; Yu, Z | 1 |
Craver, EC; Heckman, MG; Mohseni, M; Sheele, JM | 1 |
Coetzee, R; Johnson, Y; Keuler, N | 1 |
Fang, Y; Li, Y; Zhang, T; Zou, P | 1 |
Dawson, C; McPherson, F; O'Flaherty, C; Revitt-Mills, SA; Robinson, A; van Oijen, AM; Vereker, M; Wright, EK | 1 |
Corcoran, GD; Finn, K; Lucey, B; O'Grady, MC; Whelan, S | 1 |
Bulagonda, EP; Khamari, B; Nandi, D; Singh, S; Umapathy, S; Verma, T | 1 |
Durai, P; Goh, JC; Koh, SWC; Loh, VWK; Low, SH; Ng, TSM; Sun, LJ; Tambyah, PA; Tan, WZ; Wong, HC; Young, D | 1 |
Chua, KYL; Knox, J; Lee, LY; Wong, L; Yang, M | 1 |
3 review(s) available for ciprofloxacin and nitrofurantoin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Treatment of vancomycin-resistant enterococcal infections].
Topics: Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Daptomycin; Denmark; Drug Therapy, Combination; Gram-Positive Bacterial Infections; Humans; Linezolid; Nitrofurantoin; Tigecycline; Urinary Tract Infections; Vancomycin-Resistant Enterococci | 2018 |
Globally Vibrio cholera antibiotics resistance to RNA and DNA effective antibiotics: A systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Cephalothin; Cholera; Cholera Toxin; Ciprofloxacin; Drug Resistance, Bacterial; Furazolidone; Gatifloxacin; Humans; Levofloxacin; Microbial Sensitivity Tests; Nalidixic Acid; Nitrofurantoin; Norfloxacin; Novobiocin; Rifampin; Vibrio cholerae; Virulence Factors | 2022 |
4 trial(s) available for ciprofloxacin and nitrofurantoin
Article | Year |
---|---|
A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Anti-Infective Agents, Urinary; Ciprofloxacin; Cystitis; Dose-Response Relationship, Drug; Double-Blind Method; Escherichia coli Infections; Female; Humans; Middle Aged; Nitrofurantoin; Prospective Studies; Staphylococcal Infections; Streptococcal Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1999 |
[Antibiotic resistance of E coli isolated from healthy persons].
Topics: Adult; Amdinocillin; Ampicillin Resistance; Anti-Bacterial Agents; Cefuroxime; Ciprofloxacin; Double-Blind Method; Drug Resistance, Multiple; Escherichia coli; Feces; Female; Humans; Male; Middle Aged; Nitrofurantoin; Penicillin Resistance; Prospective Studies; Trimethoprim Resistance | 2001 |
Women's quality of life is decreased by acute cystitis and antibiotic adverse effects associated with treatment.
Topics: Acute Disease; Adult; Anti-Infective Agents, Urinary; Ciprofloxacin; Cystitis; Female; Humans; Middle Aged; Nitrofurantoin; Outcome and Process Assessment, Health Care; Patient Compliance; Quality of Life; Surveys and Questionnaires; Trimethoprim, Sulfamethoxazole Drug Combination | 2005 |
Effective antimicrobial stewardship in a long-term care facility through an infectious disease consultation service: keeping a LID on antibiotic use.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Ciprofloxacin; Clindamycin; Clostridioides difficile; Enterocolitis, Pseudomembranous; Humans; Infectious Disease Medicine; Long-Term Care; Nitrofurantoin; Nursing Homes; Referral and Consultation; Regression Analysis; Tetracyclines; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2012 |
98 other study(ies) available for ciprofloxacin and nitrofurantoin
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen | 2007 |
Colistin methanesulfonate against multidrug-resistant Acinetobacter baumannii in an in vitro pharmacodynamic model.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Ceftazidime; Colistin; Colony Count, Microbial; Drug Combinations; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests | 2007 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Reduced Susceptibility of Proteus mirabilis to triclosan.
Topics: Anti-Infective Agents, Local; Biofilms; Colony Count, Microbial; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Models, Anatomic; Mutation; Proteus mirabilis; Triclosan; Urinary Bladder; Urinary Catheterization | 2008 |
Presence of plasmid-mediated quinolone resistance in Klebsiella pneumoniae isolates possessing blaKPC in the United States.
Topics: Aged; Bacterial Proteins; Base Sequence; beta-Lactamases; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Molecular Epidemiology; Plasmids; Quinolones; United States | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Mechanism and fitness costs of PR-39 resistance in Salmonella enterica serovar Typhimurium LT2.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Bacterial Proteins; Cathelicidins; Drug Resistance, Multiple, Bacterial; Female; Genetic Complementation Test; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Models, Genetic; Mutagenesis, Insertional; Mutation; Salmonella Infections, Animal; Salmonella typhimurium; Sequence Deletion | 2008 |
Oral and parenteral therapeutic options for outpatient urinary infections caused by enterobacteriaceae producing CTX-M extended-spectrum beta-lactamases.
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefdinir; Cephalosporins; Cross Infection; Enterobacteriaceae; Ertapenem; Escherichia coli; Fosfomycin; Humans; Infusions, Parenteral; Microbial Sensitivity Tests; Outpatients; Urinary Tract Infections | 2009 |
Molecular characteristics of travel-related extended-spectrum-beta-lactamase-producing Escherichia coli isolates from the Calgary Health Region.
Topics: beta-Lactamases; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Fluoroquinolones; Humans; Travel | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
High prevalence of ST131 isolates producing CTX-M-15 and CTX-M-14 among extended-spectrum-beta-lactamase-producing Escherichia coli isolates from Canada.
Topics: Bacterial Typing Techniques; beta-Lactamases; Canada; Community-Acquired Infections; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Prevalence; Urinary Tract Infections | 2010 |
Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Cell Membrane Permeability; Cells, Cultured; Drug Resistance, Bacterial; Endosomes; Escherichia coli; Escherichia coli Infections; Female; Humans; Mice; Mice, Inbred CBA; Microbial Sensitivity Tests; Recurrence; Urinary Bladder; Urinary Tract Infections; Urothelium | 2010 |
Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum beta-lactamases: a prospective study with Swedish volunteers.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; beta-Lactamases; Child; Child, Preschool; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Prospective Studies; Risk Factors; Sweden; Travel; White People; Young Adult | 2010 |
Oral treatment options for ambulatory patients with urinary tract infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli.
Topics: Amdinocillin Pivoxil; Anti-Bacterial Agents; beta-Lactamases; Escherichia coli; Escherichia coli Infections; Fosfomycin; Humans; Microbial Sensitivity Tests; Nitrofurantoin; Urinary Tract Infections | 2010 |
QSAR-based solubility model for drug-like compounds.
Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water | 2010 |
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Prediction of Antibiotic Interactions Using Descriptors Derived from Molecular Structure.
Topics: Anti-Bacterial Agents; Drug Interactions; Molecular Structure | 2017 |
Novel pyridyl nitrofuranyl isoxazolines show antibacterial activity against multiple drug resistant Staphylococcus species.
Topics: Anti-Bacterial Agents; Cell Line, Tumor; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Nitrofurantoin; Oxazoles; Spectrum Analysis; Staphylococcus aureus; Structure-Activity Relationship | 2017 |
Comparative in vitro activities of six new fluoroquinolones and other oral antimicrobial agents against Campylobacter pylori.
Topics: Ampicillin; Anti-Infective Agents; Campylobacter; Ciprofloxacin; Colony Count, Microbial; Erythromycin; Microbial Sensitivity Tests; Nitrofurantoin; Sulfamethoxazole; Tetracycline; Trimethoprim | 1989 |
Susceptibility of different isolates of Vibrio harveyi to antibiotics.
Topics: Animals; Anti-Bacterial Agents; Chloramphenicol; Ciprofloxacin; Decapoda; Doxycycline; Drug Resistance, Microbial; Erythromycin; Fish Diseases; Fishes; Microbial Sensitivity Tests; Nalidixic Acid; Nitrofurantoin; Novobiocin; Oxolinic Acid; Oxytetracycline; Penicillins; Seawater; Streptomycin; Sulfonamides; Vancomycin; Vibrio; Vibrio Infections; Water Microbiology | 1997 |
Economic assessment of three antimicrobial therapies for uncomplicated urinary tract infection in women.
Topics: Adolescent; Adult; Anti-Infective Agents; Ciprofloxacin; Female; Humans; Insurance, Health, Reimbursement; Medicaid; Middle Aged; Nitrofurantoin; North Carolina; Polypharmacy; Sulfamethoxazole; Time Factors; Treatment Outcome; Trimethoprim; United States; Urinary Tract Infections | 1999 |
A Canadian national surveillance study of urinary tract isolates from outpatients: comparison of the activities of trimethoprim-sulfamethoxazole, ampicillin, mecillinam, nitrofurantoin, and ciprofloxacin. The Canadian Urinary Isolate Study Group.
Topics: Amdinocillin; Ampicillin; Anti-Infective Agents; Anti-Infective Agents, Urinary; Canada; Ciprofloxacin; Drug Resistance, Microbial; Escherichia coli; Microbial Sensitivity Tests; Nitrofurantoin; Penicillins; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2000 |
Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States.
Topics: Ampicillin; Anti-Infective Agents; Anti-Infective Agents, Urinary; Ciprofloxacin; Databases, Factual; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Female; Geography; Humans; Microbial Sensitivity Tests; Nitrofurantoin; Outpatients; Penicillins; Phenotype; Trimethoprim, Sulfamethoxazole Drug Combination; United States; Urinary Tract Infections | 2002 |
[Urinary microflora in children from different pediatric departments].
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cephalosporins; Child; Ciprofloxacin; Escherichia coli; Gentamicins; Humans; Inpatients; Microbial Sensitivity Tests; Nitrofurantoin; Outpatients; Staphylococcus aureus; Urine | 2003 |
[Urinary tract pathogens in uncomplicated lower urinary tract infections in women in Norway].
Topics: Adult; Aged; Amdinocillin; Ampicillin; Ampicillin Resistance; Anti-Infective Agents, Urinary; Bacteriuria; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Middle Aged; Nitrofurantoin; Penicillins; Trimethoprim Resistance; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2003 |
[Distribution and resistance trends of pathogens from urinary tract infections and impact on management].
Topics: Ciprofloxacin; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Nitrofurantoin; Urinary Tract Infections | 2003 |
Antitumor activity of common antibiotics against superficial bladder cancer.
Topics: Antibiotics, Antineoplastic; Carcinoma, Transitional Cell; Cefazolin; Cell Line, Tumor; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Genes, p53; Humans; Nitrofurantoin; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Bladder Neoplasms | 2004 |
Diabetes mellitus in itself is not a risk factor for antibiotic resistance in Escherichia coli isolated from patients with bacteriuria.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents; Bacteriuria; Ciprofloxacin; Diabetes Complications; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Middle Aged; Nitrofurantoin; Norfloxacin; Ofloxacin; Risk Factors; Trimethoprim, Sulfamethoxazole Drug Combination | 2004 |
[Antibiotic susceptibility analysis of Enterococcus spp. isolated from urine].
Topics: Anti-Bacterial Agents; Child; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Gentamicins; Humans; Microbial Sensitivity Tests; Nitrofurantoin; Penicillins; Poland; Streptomycin; Teicoplanin; Tetracycline; Urinary Tract Infections; Vancomycin | 2004 |
Fluoroquinolone-resistant urinary isolates of Escherichia coli from outpatients are frequently multidrug resistant: results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance study.
Topics: Adolescent; Adult; Ampicillin; Anti-Infective Agents, Urinary; Cefdinir; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; In Vitro Techniques; Male; Microbial Sensitivity Tests; Middle Aged; Nitrofurantoin; North America; Outpatients; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2006 |
Antibiotic resistance of urinary tract pathogens and evaluation of empirical treatment in Turkish children with urinary tract infections.
Topics: Adolescent; Age Factors; Amikacin; Ampicillin; Antibiotic Prophylaxis; Bacterial Infections; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Female; Gentamicins; Humans; Infant; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Nitrofurantoin; Trimethoprim, Sulfamethoxazole Drug Combination; Turkey; Urinary Tract Infections | 2006 |
Ten years surveillance of antimicrobial susceptibility of community-acquired Escherichia coli and other uropathogens in northern Israel (1995-2005).
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents, Urinary; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Gram-Negative Bacteria; Humans; Israel; Microbial Sensitivity Tests; Nitrofurantoin; Population Surveillance; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2007 |
Common antibiotics for the treatment of urinary tract infections.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Costs; Humans; Nitrofurantoin; Nurse's Role; Ofloxacin; Patient Education as Topic; Patient Selection; Sulfamethoxazole; Urinary Tract Infections | 2008 |
Antibiotic resistance in urinary isolates of Escherichia coli from college women with urinary tract infections.
Topics: Adolescent; Adult; Ciprofloxacin; Drug Resistance, Microbial; Escherichia coli; Female; Humans; Nitrofurantoin; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections; Young Adult | 2009 |
High resistance prevalence towards ampicillin, co-trimoxazole and ciprofloxacin, among uropathogenic Escherichia coli isolates in Mexico City.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Escherichia coli Infections; Female; Humans; Mexico; Microbial Sensitivity Tests; Netilmicin; Nitrofurantoin; Pregnancy; Prevalence; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections; Uropathogenic Escherichia coli | 2008 |
Antibiotic resistance in pathogens causing community-acquired urinary tract infections in India: a multicenter study.
Topics: Adolescent; Adult; Aged; Ampicillin; Anti-Infective Agents, Urinary; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; India; Middle Aged; Nitrofurantoin; Retrospective Studies; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2008 |
Antimicrobial resistance in more than 100,000 Escherichia coli isolates according to culture site and patient age, gender, and location.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Ampicillin; Anti-Bacterial Agents; Cefotaxime; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fosfomycin; Humans; Imipenem; Infant; Male; Middle Aged; Nitrofurantoin; Retrospective Studies; Tobramycin; Young Adult | 2011 |
Inequality in quality? Regional and educational differences in treatment with fluoroquinolone in urinary tract infection of 236,376 Swedish patients.
Topics: Adolescent; Adult; Age Distribution; Amdinocillin Pivoxil; Anti-Infective Agents, Urinary; Ciprofloxacin; Drug Utilization; Female; Fluoroquinolones; Guideline Adherence; Healthcare Disparities; Humans; Middle Aged; Multivariate Analysis; Nitrofurantoin; Norfloxacin; Practice Patterns, Physicians'; Quality Indicators, Health Care; Risk Adjustment; Social Class; Sweden; Trimethoprim; Urinary Tract Infections | 2011 |
Emergence of community-acquired extended-spectrum beta-lactamase Escherichia coli (ESBLEC) in Honolulu: a case series of three individuals with community-acquired ESBLEC bacteriuria.
Topics: Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Bacteriuria; beta-Lactamases; Ciprofloxacin; Community-Acquired Infections; Escherichia coli; Escherichia coli Infections; Female; Hawaii; Humans; Male; Meropenem; Middle Aged; Nitrofurantoin; Risk Factors; Thienamycins | 2011 |
In vitro antimicrobial resistance of urinary Escherichia coli isolates among U.S. outpatients from 2000 to 2010.
Topics: Ceftriaxone; Cephalosporin Resistance; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Nitrofurantoin; Outpatients; Population Surveillance; Trimethoprim Resistance; Trimethoprim, Sulfamethoxazole Drug Combination; United States; Urinary Tract Infections | 2012 |
A case of New Delhi metallo-β-lactamase 1 (NDM-1)-producing Klebsiella pneumoniae with putative secondary transmission from the Balkan region in the Netherlands.
Topics: Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Ciprofloxacin; Coinfection; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Multilocus Sequence Typing; Nitrofurantoin; Staphylococcal Infections; Travel | 2012 |
Decreased susceptibility to noncarbapenem antimicrobials in extended-spectrum-β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates in Toronto, Canada.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Nitrofurantoin; Retrospective Studies | 2012 |
An 11-year analysis of the prevalent uropathogens and the changing pattern of Escherichia coli antibiotic resistance in 38,530 community urinary tract infections, Dublin 1999-2009.
Topics: Adolescent; Adult; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Cefuroxime; Child; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Gentamicins; Humans; Incidence; Male; Microbial Sensitivity Tests; Nitrofurantoin; Prevalence; Retrospective Studies; Time Factors; Trimethoprim; Urinary Tract Infections | 2013 |
Antibiotic resistance in urinary tract infections in college students.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Ciprofloxacin; Drug Resistance, Microbial; Female; Humans; Nitrofurantoin; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Students; Universities; Urinary Tract Infections; Women's Health; Young Adult | 2012 |
Resistance profiles of urinary tract infections in general practice--an observational study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli Infections; Female; Fosfomycin; General Practice; Germany; Gram-Positive Bacterial Infections; Humans; Klebsiella Infections; Microbial Sensitivity Tests; Middle Aged; Nitrofurantoin; Prospective Studies; Trimethoprim; Urinary Tract Infections; Young Adult | 2012 |
Phenotypic and molecular antibiotic resistance profile of Enterococcus faecalis and Enterococcus faecium isolated from different traditional fermented foods.
Topics: Ampicillin; Bacterial Proteins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Erythromycin; Fermentation; Food Contamination; Food Microbiology; Genes, Bacterial; Gentamicins; Levofloxacin; Microbial Sensitivity Tests; Nitrofurantoin; Ofloxacin; Penicillins; Phenotype; Vancomycin | 2013 |
Increasing prevalence of ciprofloxacin resistance in extended-spectrum-β-lactamase-producing Escherichia coli urinary isolates.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Ciprofloxacin; Contraindications; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fosfomycin; Humans; Male; Middle Aged; Nitrofurantoin; Prevalence; Retrospective Studies; Treatment Failure; Treatment Outcome; Urinary Tract; Urinary Tract Infections; Young Adult | 2013 |
Sex- and age-specific trends in antibiotic resistance patterns of Escherichia coli urinary isolates from outpatients.
Topics: Adolescent; Adult; Age Factors; Aged; Ambulatory Care; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Cross-Sectional Studies; Drug Resistance, Bacterial; Escherichia coli; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Nitrofurantoin; Sex Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections; Young Adult | 2013 |
Microbiology of urinary tract infections in Gaborone, Botswana.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Botswana; Ciprofloxacin; Comorbidity; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; HIV Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Nitrofurantoin; Retrospective Studies; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2013 |
Molecular subtyping and virulence gene analysis of Listeria monocytogenes isolates from food.
Topics: Animals; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Ciprofloxacin; Cloning, Molecular; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Food Contamination; Food Microbiology; Heat-Shock Proteins; Hemolysin Proteins; Listeria monocytogenes; Meat; Microbial Sensitivity Tests; Nitrofurantoin; Phylogeny; Serotyping; Tetracycline; Virulence | 2013 |
Incidence of Shiga toxin-producing Escherichia coli serogroups in ruminant's meat.
Topics: Abattoirs; Animals; Anti-Bacterial Agents; Camelus; Cattle; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli Proteins; Food Contamination; Food Microbiology; Goats; Iran; Meat; Nitrofurantoin; Penicillins; Polymerase Chain Reaction; Ruminants; Sheep; Shiga-Toxigenic Escherichia coli; Virulence Factors | 2013 |
Urinary tract infection caused by Enterococcus isolates: aetiology and antimicrobial resistance patterns.
Topics: Academic Medical Centers; Ampicillin Resistance; Anti-Infective Agents, Urinary; China; Ciprofloxacin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Electronic Health Records; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Nitrofurantoin; Retrospective Studies; Species Specificity; Urinary Tract Infections | 2015 |
Susceptibility of Escherichia coli from community-acquired urinary tract infection to fosfomycin, nitrofurantoin, and temocillin in Korea.
Topics: Anti-Bacterial Agents; Cefepime; Cell Survival; Cephalosporins; Ciprofloxacin; Community-Acquired Infections; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fosfomycin; Humans; Nitrofurantoin; Penicillins; Republic of Korea; Sulfadoxine; Treatment Outcome; Trimethoprim; Urinary Tract Infections | 2014 |
Sweet syndrome with panniculitis, arthralgia, episcleritis, and neurologic involvement precipitated by antibiotics.
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Arthralgia; Ciprofloxacin; Female; Headache; Humans; Middle Aged; Nitrofurantoin; Panniculitis; Scleritis; Sweet Syndrome | 2014 |
Collateral damage from oral ciprofloxacin versus nitrofurantoin in outpatients with urinary tract infections: a culture-free analysis of gut microbiota.
Topics: Adult; Anti-Bacterial Agents; Bacteria; Ciprofloxacin; DNA, Bacterial; DNA, Ribosomal; Feces; Female; Gastrointestinal Microbiome; Humans; Male; Middle Aged; Nitrofurantoin; Outpatients; Prospective Studies; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Urinary Tract Infections; Young Adult | 2015 |
Kidney function and the use of nitrofurantoin to treat urinary tract infections in older women.
Topics: Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Ciprofloxacin; Female; Glomerular Filtration Rate; Humans; Nitrofurantoin; Norfloxacin; Renal Insufficiency; Retrospective Studies; Sex Factors; Treatment Failure; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2015 |
Activity of fosfomycin and comparison of several susceptibility testing methods against contemporary urine isolates.
Topics: Anti-Bacterial Agents; Bacteriuria; Ciprofloxacin; Cystitis; Drug Resistance, Bacterial; Enterobacteriaceae; Enterococcus; Female; Fosfomycin; Humans; Microbial Sensitivity Tests; Nitrofurantoin; Pseudomonas aeruginosa; Urinary Bladder | 2015 |
Local audit: How tightly should we police antibiotic prescribing for urinary tract infection and how should we modify national policy?
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ciprofloxacin; Clinical Audit; Drug Resistance, Bacterial; England; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Gentamicins; Health Policy; Humans; Meropenem; Microbial Sensitivity Tests; Nitrofurantoin; Practice Guidelines as Topic; Thienamycins; Trimethoprim; Urinary Tract Infections | 2015 |
Susceptibility of Multidrug-Resistant Gram-Negative Urine Isolates to Oral Antibiotics.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fosfomycin; Microbial Sensitivity Tests; Nitrofurantoin; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2016 |
Antibiotic Resistance among Urinary Isolates from Female Outpatients in the United States in 2003 and 2012.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Infant; Infant, Newborn; Microbial Sensitivity Tests; Nitrofurantoin; Retrospective Studies; Trimethoprim, Sulfamethoxazole Drug Combination | 2016 |
Escherichia coli antimicrobial susceptibility profile and cumulative antibiogram to guide empirical treatment of uncomplicated urinary tract infections in women in the province of Québec, 2010-15.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Ciprofloxacin; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Nitrofurantoin; Outpatients; Quebec; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections; Urine; Young Adult | 2016 |
Antibiotic Resistance of Bacteria Involved in Urinary Infections in Brazil: A Cross-Sectional and Retrospective Study.
Topics: Ampicillin; Anti-Bacterial Agents; Brazil; Ciprofloxacin; Cross-Sectional Studies; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Nitrofurantoin; Retrospective Studies; Sulbactam; Urinary Tract Infections | 2016 |
Comparison of UTI antibiograms stratified by ED patient disposition.
Topics: Adult; Aged; Anti-Bacterial Agents; Ciprofloxacin; Cross-Sectional Studies; Drug Resistance, Bacterial; Emergency Service, Hospital; Escherichia coli; Escherichia coli Infections; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Nitrofurantoin; Trimethoprim, Sulfamethoxazole Drug Combination; United States; Urinary Tract Infections | 2017 |
Sensitivity to Antibiotics of Bacteria Exposed to Gamma Radiation Emitted from Hot Soils of the High Background Radiation Areas of Ramsar, Northern Iran.
Topics: Anti-Bacterial Agents; Background Radiation; Cephalexin; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Gamma Rays; Iran; Klebsiella pneumoniae; Nitrofurantoin; Salmonella typhimurium; Soil; Staphylococcus aureus | 2017 |
Assessment of the comparability of CLSI, EUCAST and Stokes antimicrobial susceptibility profiles for Escherichia coli uropathogenic isolates.
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Bacteriuria; Cephalexin; Cephradine; Ciprofloxacin; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Nitrofurantoin; Practice Guidelines as Topic; Trimethoprim; Urinary Tract Infections; Uropathogenic Escherichia coli | 2018 |
Effect of general practice characteristics and antibiotic prescribing on Escherichia coli antibiotic non-susceptibility in the West Midlands region of England: a 4 year ecological study.
Topics: Adolescent; Adult; Aged; Ampicillin; Anti-Bacterial Agents; Antimicrobial Stewardship; Ciprofloxacin; Drug Resistance, Bacterial; Ecological and Environmental Phenomena; England; Escherichia coli; Escherichia coli Infections; Female; General Practice; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Nitrofurantoin; Practice Patterns, Physicians'; Retrospective Studies; Seasons; Urinary Tract Infections; Young Adult | 2018 |
Alterations of growth rate and gene expression levels of UPEC by antibiotics at sub-MIC.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Ciprofloxacin; Escherichia coli Proteins; Gene Expression Regulation, Bacterial; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Nitrofurantoin; Trimethoprim, Sulfamethoxazole Drug Combination; Uropathogenic Escherichia coli; Virulence | 2018 |
Epizootics of Pseudomonas anguilliseptica among cultured seabream (Sparus aurata) populations: Control and treatment strategies.
Topics: Animal Feed; Animals; Anti-Bacterial Agents; Aquaculture; Ciprofloxacin; Dietary Supplements; Egypt; Fish Diseases; Formates; Garlic; Hydrogen-Ion Concentration; Molecular Weight; Nitrofurantoin; Plant Extracts; Polymorphism, Restriction Fragment Length; Prevalence; Pseudomonas; Pseudomonas Infections; Sea Bream; Thiamphenicol | 2018 |
Conserved collateral antibiotic susceptibility networks in diverse clinical strains of Escherichia coli.
Topics: Amdinocillin; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Genetic Predisposition to Disease; Genetic Variation; Humans; Microbial Sensitivity Tests; Models, Statistical; Multivariate Analysis; Mutation; Nitrofurantoin; Phylogeny; Trimethoprim; Urinary Tract Infections | 2018 |
Biocide Exposure Induces Changes in Susceptibility, Pathogenicity, and Biofilm Formation in Uropathogenic
Topics: Animals; Anti-Bacterial Agents; Benzalkonium Compounds; Biguanides; Biofilms; Catheter-Related Infections; Cell Line; Ciprofloxacin; Disinfectants; Drug Resistance, Bacterial; Escherichia coli Infections; Gentamicins; L Cells; Mice; Microbial Sensitivity Tests; Moths; Nitrofurantoin; Silver Nitrate; Triclosan; Trimethoprim, Sulfamethoxazole Drug Combination; Uropathogenic Escherichia coli; Virulence | 2019 |
Uncomplicated urinary tract infections in Swedish primary care; etiology, resistance and treatment.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Ciprofloxacin; Drug Prescriptions; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Middle Aged; Nitrofurantoin; Prevalence; Primary Health Care; Prospective Studies; Sweden; Urinary Tract Infections | 2019 |
The Role of Ciprofloxacin Resistance and Extended-spectrum beta-lactamase (ESBL) Positivity in Infective Complications Following Prostate Biopsy.
Topics: Amikacin; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactamases; Biopsy; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Humans; Male; Middle Aged; Needs Assessment; Nitrofurantoin; Prostatic Neoplasms; Rectum; Urinary Tract Infections | 2020 |
Antimicrobial resistance of gram-negative bacteria: A six-year longitudinal study in a hospital in Saudi Arabia.
Topics: Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Gram-Negative Bacteria; Hospitals; Humans; Klebsiella pneumoniae; Longitudinal Studies; Microbial Sensitivity Tests; Nitrofurantoin; Pseudomonas aeruginosa; Saudi Arabia; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination | 2020 |
Exposure to sub-inhibitory ciprofloxacin and nitrofurantoin concentrations increases recA gene expression in uropathogenic Escherichia coli: The role of RecA protein as a drug target.
Topics: Anti-Infective Agents, Urinary; Ciprofloxacin; DNA-Binding Proteins; Escherichia coli Proteins; Genes, Bacterial; Microbial Sensitivity Tests; Molecular Docking Simulation; Nitrofurantoin; Rec A Recombinases; Uropathogenic Escherichia coli | 2020 |
Effect of different drugs and drug combinations on killing stationary phase and biofilms recovered cells of Bartonella henselae in vitro.
Topics: Analgesics; Azithromycin; Bartonella henselae; Biofilms; Ciprofloxacin; Drug Combinations; Drug Therapy, Combination; Gentamicins; Methylene Blue; Microbial Sensitivity Tests; Microbial Viability; Nitrofurantoin; Rifampin | 2020 |
Office-based approach to urinary tract infections in 50 000 patients: results from the REWIND study.
Topics: Adult; Ambulatory Care; Anti-Bacterial Agents; Belgium; Brazil; Ciprofloxacin; Female; Fosfomycin; Guidelines as Topic; Humans; Italy; Middle Aged; Nitrofurantoin; Practice Patterns, Physicians'; Russia; Urinary Tract Infections | 2020 |
Antibiogram and molecular characterization of multi-drug resistant microorganisms isolated from urinary tract infections.
Topics: Amikacin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Gentamicins; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Nitrofurantoin; Oxacillin; Pakistan; Pipemidic Acid; Piperacillin, Tazobactam Drug Combination; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2021 |
Community-Acquired Uropathogenic
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Cefazolin; Ciprofloxacin; Colistin; Cross-Sectional Studies; Cuba; Escherichia coli Proteins; Fosfomycin; Humans; Microbial Sensitivity Tests; Nitrofurantoin; Sulbactam; Sulfamethoxazole; Trimethoprim; Urinary Tract Infections; Uropathogenic Escherichia coli | 2022 |
Prevalence and antimicrobial susceptibility of Enterococcus spp. from urine of dogs and cats in northwestern Croatia.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cat Diseases; Cats; Chloramphenicol; Ciprofloxacin; Croatia; Dog Diseases; Dogs; Drug Resistance, Bacterial; Enrofloxacin; Enterococcus; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Nitrofurantoin; Penicillins; Prevalence; Rifampin; Streptomycin; Tetracycline; Vancomycin | 2022 |
High antimicrobial resistance in urinary tract infections in male outpatients in routine laboratory data, Germany, 2015 to 2020.
Topics: Adult; Aged, 80 and over; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fosfomycin; Humans; Laboratories; Male; Microbial Sensitivity Tests; Nitrofurantoin; Outpatients; Proteus mirabilis; Urinary Tract Infections | 2022 |
Assessment of Bacterial Isolates from the Urine Specimens of Urinary Tract Infected Patient.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Nitrofurantoin; Ofloxacin; Urinary Tract; Urinary Tract Infections | 2022 |
Assessment of nationally recommended antibiotics for treatment of UTI in U.S.-Mexico border emergency departments.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefdinir; Cefuroxime; Cephalexin; Ciprofloxacin; Emergency Service, Hospital; Fluoroquinolones; Humans; Levofloxacin; Mexico; Nitrofurantoin; Retrospective Studies; Tetracyclines; Trimethoprim, Sulfamethoxazole Drug Combination; United States; Urinary Tract Infections | 2022 |
Combinatorial screening SlipChip for rapid phenotypic antimicrobial susceptibility testing.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Ceftazidime; Ciprofloxacin; Escherichia coli; Humans; Nitrofurantoin | 2022 |
Can Urinalysis and Past Medical History of Kidney Stones Predict Urine Antibiotic Resistance?
Topics: Anti-Bacterial Agents; Cefazolin; Ciprofloxacin; Drug Resistance, Microbial; Female; Humans; Kidney Calculi; Nitrofurantoin; Trimethoprim, Sulfamethoxazole Drug Combination; Urinalysis; Urinary Tract Infections | 2022 |
Treating urinary tract infections in public sector primary healthcare facilities in Cape Town, South Africa: A pharmaceutical perspective.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Female; Humans; Male; Microscopy; Nitrofurantoin; Primary Health Care; Public Sector; South Africa; Urinalysis; Urinary Tract Infections | 2022 |
Physiologically based pharmacokinetic model to predict drug concentrations of breast cancer resistance protein substrates in milk.
Topics: Acyclovir; ATP Binding Cassette Transporter, Subfamily G, Member 2; Bupropion; Cimetidine; Ciprofloxacin; Female; Humans; Infant; Lactation; Milk, Human; Models, Biological; Neoplasm Proteins; Nitrofurantoin | 2022 |
Defects in DNA double-strand break repair resensitize antibiotic-resistant Escherichia coli to multiple bactericidal antibiotics.
Topics: Anti-Bacterial Agents; Ciprofloxacin; DNA Repair; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Nitrofurantoin; Trimethoprim | 2022 |
Effect of Sub-Inhibitory Concentrations of Nitrofurantoin, Ciprofloxacin, and Trimethoprim on In Vitro Biofilm Formation in Uropathogenic
Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Humans; Nitrofurantoin; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections; Uropathogenic Escherichia coli | 2022 |
Antimicrobial Resistance Studies Using Raman Spectroscopy on Clinically Relevant Bacterial Strains.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Drug Resistance, Bacterial; Gentamicins; Lipids; Meropenem; Microbial Sensitivity Tests; Nitrofurantoin; Spectrum Analysis, Raman | 2023 |
Antibiotic treatment failure of uncomplicated urinary tract infections in primary care.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Female; Humans; Nitrofurantoin; Primary Health Care; Retrospective Studies; Treatment Failure; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2023 |
Antimicrobial resistance and its detection in Staphylococcus saprophyticus urinary isolates.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Nitrofurantoin; Staphylococcus saprophyticus; Trimethoprim, Sulfamethoxazole Drug Combination | 2023 |